MSI
7 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies (NCT03652077) | Incyte Corporation | 2018-09-24 |
| Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer (NCT03186326) | Federation Francophone de Cancerologie Digestive | 2018-04-24 |
| Study With Atezolizumab Plus Bevacizumab in Patients With Chemotherapy Resistant, MSI-like, Colorectal Cancer (NCT02982694) | Vall d'Hebron Institute of Oncology | 2017-11-24 |
Track MSI automatically
Every clearance here is in the API, with alerts when new ones post.